Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:l-ornithine l-aspartate-containing product in oral dose form'
(id=14007561 ; fe=en:l-ornithine l-aspartate-containing product in oral dose form ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1864 creation date=2019-12-07 touchdate=2024-09-19 01:22:32.000)
≈ 60 relations sortantes

  1. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:abacavir-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:abacavir-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  2. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:acipimox-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:acipimox-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  3. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:albendazole-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:albendazole-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  4. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:amlodipine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:amlodipine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  5. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:amodiaquine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:amodiaquine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  6. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:anastrozole-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:anastrozole-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  7. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:artemether- and lumefantrine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:artemether- and lumefantrine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  8. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:artesunate-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:artesunate-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  9. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:azithromycin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:azithromycin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  10. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:bedaquiline-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:bedaquiline-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  11. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:bicalutamide-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:bicalutamide-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  12. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:capecitabine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:capecitabine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  13. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:chlorambucil-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:chlorambucil-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  14. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:ciprofloxacin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:ciprofloxacin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  15. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:clomiphene-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:clomiphene-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  16. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:clomipramine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:clomipramine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  17. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:clopidogrel-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:clopidogrel-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  18. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:conjugated estrogen-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:conjugated estrogen-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  19. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:cyclizine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:cyclizine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  20. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:cyclophosphamide-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:cyclophosphamide-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  21. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:cycloserine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:cycloserine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  22. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:daclatasvir-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:daclatasvir-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  23. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:dasabuvir-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:dasabuvir-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  24. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:deferasirox-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:deferasirox-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  25. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:diloxanide-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:diloxanide-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  26. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:enalapril-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:enalapril-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  27. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:entecavir-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:entecavir-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  28. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:ethosuximide-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:ethosuximide-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  29. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:etoposide-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:etoposide-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  30. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:fludarabine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:fludarabine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  31. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:folic acid-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:folic acid-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  32. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:gatifloxacin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:gatifloxacin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  33. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:gliclazide-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:gliclazide-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  34. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:hydroxyurea-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:hydroxyurea-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  35. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:imatinib-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:imatinib-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  36. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:ivermectin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:ivermectin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  37. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:leucovorin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:leucovorin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  38. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:levofloxacin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:levofloxacin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  39. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:mefloquine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:mefloquine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  40. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:mercaptopurine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:mercaptopurine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  41. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:mesna-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:mesna-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  42. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:metoprolol-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:metoprolol-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  43. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:ofloxacin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:ofloxacin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  44. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:omeprazole-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:omeprazole-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  45. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:ondansetron-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:ondansetron-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  46. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:oxacillin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:oxacillin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  47. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:oxamniquine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:oxamniquine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  48. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:paromomycin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:paromomycin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  49. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:plant fiber-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:plant fiber-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  50. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:simeprevir-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:simeprevir-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  51. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:simvastatin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:simvastatin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  52. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:sofosbuvir-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:sofosbuvir-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  53. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:spironolactone-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:spironolactone-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  54. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:succimer-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:succimer-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  55. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:sulfadiazine-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:sulfadiazine-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  56. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:tamoxifen-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:tamoxifen-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  57. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:tranexamic acid-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:tranexamic acid-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  58. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:trovafloxacin-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:trovafloxacin-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  59. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:valganciclovir-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:valganciclovir-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  60. en:l-ornithine l-aspartate-containing product in oral dose form -- r_associated #0: 20 / 1 -> en:zinc sulfate-containing product in oral dose form
    n1=en:l-ornithine l-aspartate-containing product in oral dose form | n2=en:zinc sulfate-containing product in oral dose form | rel=r_associated | relid=0 | w=20
≈ 60 relations entrantes

  1. en:oxamniquine-containing product in oral dose form --- r_associated #0: 43 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:oxamniquine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=43
  2. en:folic acid-containing product in oral dose form --- r_associated #0: 40 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:folic acid-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=40
  3. en:amodiaquine-containing product in oral dose form --- r_associated #0: 38 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:amodiaquine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=38
  4. en:ciprofloxacin-containing product in oral dose form --- r_associated #0: 37 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:ciprofloxacin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=37
  5. en:ivermectin-containing product in oral dose form --- r_associated #0: 37 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:ivermectin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=37
  6. en:cyclizine-containing product in oral dose form --- r_associated #0: 35 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:cyclizine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=35
  7. en:mefloquine-containing product in oral dose form --- r_associated #0: 35 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:mefloquine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=35
  8. en:plant fiber-containing product in oral dose form --- r_associated #0: 35 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:plant fiber-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=35
  9. en:simvastatin-containing product in oral dose form --- r_associated #0: 35 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:simvastatin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=35
  10. en:sofosbuvir-containing product in oral dose form --- r_associated #0: 35 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:sofosbuvir-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=35
  11. en:spironolactone-containing product in oral dose form --- r_associated #0: 35 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:spironolactone-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=35
  12. en:azithromycin-containing product in oral dose form --- r_associated #0: 34 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:azithromycin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=34
  13. en:leucovorin-containing product in oral dose form --- r_associated #0: 34 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:leucovorin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=34
  14. en:oxacillin-containing product in oral dose form --- r_associated #0: 34 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:oxacillin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=34
  15. en:sulfadiazine-containing product in oral dose form --- r_associated #0: 34 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:sulfadiazine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=34
  16. en:zinc sulfate-containing product in oral dose form --- r_associated #0: 34 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:zinc sulfate-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=34
  17. en:anastrozole-containing product in oral dose form --- r_associated #0: 32 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:anastrozole-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=32
  18. en:bedaquiline-containing product in oral dose form --- r_associated #0: 32 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:bedaquiline-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=32
  19. en:ethosuximide-containing product in oral dose form --- r_associated #0: 32 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:ethosuximide-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=32
  20. en:fludarabine-containing product in oral dose form --- r_associated #0: 32 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:fludarabine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=32
  21. en:gliclazide-containing product in oral dose form --- r_associated #0: 32 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:gliclazide-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=32
  22. en:albendazole-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:albendazole-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  23. en:chlorambucil-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:chlorambucil-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  24. en:clomipramine-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:clomipramine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  25. en:conjugated estrogen-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:conjugated estrogen-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  26. en:cycloserine-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:cycloserine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  27. en:diloxanide-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:diloxanide-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  28. en:entecavir-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:entecavir-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  29. en:levofloxacin-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:levofloxacin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  30. en:mesna-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:mesna-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  31. en:simeprevir-containing product in oral dose form --- r_associated #0: 31 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:simeprevir-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=31
  32. en:abacavir-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:abacavir-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  33. en:capecitabine-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:capecitabine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  34. en:daclatasvir-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:daclatasvir-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  35. en:enalapril-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:enalapril-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  36. en:hydroxyurea-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:hydroxyurea-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  37. en:mercaptopurine-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:mercaptopurine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  38. en:tamoxifen-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:tamoxifen-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  39. en:tranexamic acid-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:tranexamic acid-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  40. en:valganciclovir-containing product in oral dose form --- r_associated #0: 30 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:valganciclovir-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=30
  41. en:cyclophosphamide-containing product in oral dose form --- r_associated #0: 29 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:cyclophosphamide-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=29
  42. en:gatifloxacin-containing product in oral dose form --- r_associated #0: 29 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:gatifloxacin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=29
  43. en:succimer-containing product in oral dose form --- r_associated #0: 29 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:succimer-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=29
  44. en:artemether- and lumefantrine-containing product in oral dose form --- r_associated #0: 28 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:artemether- and lumefantrine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=28
  45. en:clopidogrel-containing product in oral dose form --- r_associated #0: 28 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:clopidogrel-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=28
  46. en:dasabuvir-containing product in oral dose form --- r_associated #0: 28 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:dasabuvir-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=28
  47. en:etoposide-containing product in oral dose form --- r_associated #0: 28 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:etoposide-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=28
  48. en:imatinib-containing product in oral dose form --- r_associated #0: 28 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:imatinib-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=28
  49. en:metoprolol-containing product in oral dose form --- r_associated #0: 28 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:metoprolol-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=28
  50. en:omeprazole-containing product in oral dose form --- r_associated #0: 28 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:omeprazole-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=28
  51. en:ondansetron-containing product in oral dose form --- r_associated #0: 28 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:ondansetron-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=28
  52. en:artesunate-containing product in oral dose form --- r_associated #0: 27 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:artesunate-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=27
  53. en:bicalutamide-containing product in oral dose form --- r_associated #0: 27 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:bicalutamide-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=27
  54. en:deferasirox-containing product in oral dose form --- r_associated #0: 27 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:deferasirox-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=27
  55. en:paromomycin-containing product in oral dose form --- r_associated #0: 27 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:paromomycin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=27
  56. en:acipimox-containing product in oral dose form --- r_associated #0: 26 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:acipimox-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=26
  57. en:amlodipine-containing product in oral dose form --- r_associated #0: 26 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:amlodipine-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=26
  58. en:clomiphene-containing product in oral dose form --- r_associated #0: 26 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:clomiphene-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=26
  59. en:ofloxacin-containing product in oral dose form --- r_associated #0: 26 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:ofloxacin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=26
  60. en:trovafloxacin-containing product in oral dose form --- r_associated #0: 26 --> en:l-ornithine l-aspartate-containing product in oral dose form
    n1=en:trovafloxacin-containing product in oral dose form | n2=en:l-ornithine l-aspartate-containing product in oral dose form | rel=r_associated | relid=0 | w=26
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr